{
    "2021-12-07": [
        [
            {
                "time": "2021-12-07",
                "original_text": "天坛生物：“人凝血酶原复合物”获得临床试验总结报告",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "人凝血酶原复合物",
                        "临床试验",
                        "总结报告"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-12-07",
                "original_text": "天坛生物(600161.SH)所属“人凝血酶原复合物”完成临床试验并取得总结报告",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "600161.SH",
                        "人凝血酶原复合物",
                        "临床试验",
                        "总结报告"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-12-07",
                "original_text": "天坛生物(600161.SH)：兰州血制研制的“人凝血酶原复合物”完成了临床试验并取得临床试验总结报告",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "600161.SH",
                        "兰州血制",
                        "人凝血酶原复合物",
                        "临床试验",
                        "总结报告"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2022",
                "original_text": "深度分析！十张图带您了解2022年血液制品市场企业下一个争夺点在哪里？",
                "features": {
                    "keywords": [
                        "血液制品市场",
                        "企业争夺点",
                        "2022年"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "市场分析"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}